1239587-68-8 Usage
Description
4-MaleiMidobutyric Acid Hydrazide Trifluoroacetate is a maleimide derivative characterized by its unique chemical structure and properties. It is a compound that has found applications in various fields due to its reactivity and functional groups.
Uses
Used in Biochemical Research:
4-MaleiMidobutyric Acid Hydrazide Trifluoroacetate is used as a reagent for the preparation of immunoenzymic conjugates. Its maleimide group allows for selective and efficient conjugation with thiol-containing biomolecules, such as antibodies or enzymes, which is crucial in the development of immunoassays and other diagnostic tools.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 4-MaleiMidobutyric Acid Hydrazide Trifluoroacetate is utilized as a building block for the synthesis of various drug candidates. Its maleimide functionality can be exploited to create novel compounds with potential therapeutic applications.
Used in Chemical Synthesis:
4-MaleiMidobutyric Acid Hydrazide Trifluoroacetate is also used as an intermediate in the synthesis of complex organic molecules. Its reactive maleimide group can be employed in various chemical reactions, such as Michael additions or thiol-ene reactions, to construct diverse molecular architectures.
Check Digit Verification of cas no
The CAS Registry Mumber 1239587-68-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,3,9,5,8 and 7 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1239587-68:
(9*1)+(8*2)+(7*3)+(6*9)+(5*5)+(4*8)+(3*7)+(2*6)+(1*8)=198
198 % 10 = 8
So 1239587-68-8 is a valid CAS Registry Number.
1239587-68-8Relevant articles and documents
CYTOTOXIC-DRUG DELIVERING MOLECULES TARGETING HIV (CDM-HS), CYTOTOXIC ACTIVITY AGAINST THE HUMAN IMMUNODEFICIENCY VIRUS AND METHODS OF USE
-
, (2013/11/18)
The present invention is directed to new bifunctional compounds and methods for treating HIV infections. The bifunctional small molecules, generally referred to as CDM-Hs, function through orthogonal pathways, by inhibiting the gp120-CD4 interaction, and by introducing cytotoxic moieties to gp120-expressing cells, thereby causing cell death and preventing cell infection and spread of HIV. It is shown that CDM-Hs bind to gp120 and gp-120 expressing cells competitively with CD4, and these compounds cause cell death of HIV-infected cells, thereby decreasing viral infectivity. Compounds and methods are described herein.
